Promethazine Hydrochloride/Sulfogaiacol/Pentoxyverine Citrate

盐酸异丙嗪/愈创木酚磺酸钾/枸橼酸喷托维林

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePromethazine Hydrochloride/Sulfogaiacol/Pentoxyverine Citrate
Drug Alias Name愈酚喷托异丙嗪颗粒东风新博
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA synthesis inhibitorsHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsCough
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Promethazine HydrochlorideSulfogaiacolPentoxyverine Citrate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsCough
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A